Similar articles

• Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors.

  Beauverie P, Taburet AM, Dessalles MC, Furlan V, Touzeau D. Beauverie P, et al. AIDS. 1998 Dec 24;12(18):2510-1. AIDS. 1998. PMID: 9875597 No abstract available.
• Mode of HIV transmission among seroconverted intravenous drug users (IVDUs): 1987 and 1988 cohort study.

  Nemoto T, Brown LS Jr, Primm BJ, Foster K, Chu A. Nemoto T, et al. NIDA Res Monogr. 1989;95:407-8. NIDA Res Monogr. 1989. PMID: 2641011 No abstract available.
• Zidovudine overdose.

  Kroon S, Worm AM. Kroon S, et al. Int J STD AIDS. 1991 Jan-Feb;2(1):56-7. doi: 10.1177/095646249100200113. Int J STD AIDS. 1991. PMID: 2036464 No abstract available.
• [Pharmacokinetic interactions between methadone and antiretroviral medication in HIV positive patients].

  Pérez Pons JC, Jornet Montaña S, Bonet Esteve A. Pérez Pons JC, et al. Med Clin (Barc). 2002 Jul 13;119(6):224-9. doi: 10.1016/s0025-7753(02)73369-1. Med Clin (Barc). 2002. PMID: 12200011 Review. Spanish. No abstract available.
• [Special problems of HIV-positive women who are either drug abusers or on methadone replacement therapy].

  Isernhagen K. Isernhagen K. Zentralbl Gynakol. 1999;121(11):555-7. Zentralbl Gynakol. 1999. PMID: 10612228 Review. German. No abstract available.